As a Wiser World Looks to Make a Strong Sustainable Recovery From COVID-19, Synthetic Biology to Receive New Opportunities for Growth

ReportLinker
·24 min read

Market to Reach $33. 2 Billion. The global market for Synthetic Biology is projected to reach US$33. 2 billion by the year 2027, trailing a post COVID-19 CAGR of 25. 2%, over the analysis period 2020 through 2027.

New York, Nov. 24, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Synthetic Biology Industry" - https://www.reportlinker.com/p01375238/?utm_source=GNW
With humans continuing their mindless plunder of the planet, natural habitat destruction and climate change has already set the stage for an era of pandemics. Animal-borne infectious diseases will continue to rise in the coming years, as human become the new host for displaced animal viruses. The current scenario has amplified the urgency to address environmental issues & ensure strict compliance among polluting businesses. Synthetic biology unfolds a new scientific era, in which synthetic organisms can be created to serve different purposes. The new biological research area is a nascent science and engineering discipline that seeks to integrate science with engineering for designing and building novel biological entities, including cells, genetic circuits and enzymes, or for redesigning active biological systems and living organisms, such as bacteria inexpensively and rapidly. Synthetic biology has already come out of the lab, buoyed by significant investments both from private and public organizations in organisms synthesized to produce chemicals, materials, medicines and biofuels. Synthetic biology derives its existence from advances in the fields of molecular biology, nanotechnology, engineering, chemistry, physics and computer science.

Synthetic biology enables the development of standardized and interchangeable DNA strands, which do not exist in the natural world. Synthetic biology techniques create base pair sequences from component parts, and assemble them from the beginning. This field of engineering organisms at the molecular level offers enormous potential and scope. In recent years the field of synthetic biology witnessed rapid development due to the development of CRISPR-Cas9, a gene editing tool, which was first introduced in the year 2013. This tool enables in locating, cutting, and replacing DNA at certain specific locations. Synthetic biology is expected to create huge generic capabilities to be used in bio-inspired processes and tools applicable in the industry along with the whole economy. The approach holds a tremendous potential to assist researchers in designing, creating and testing systems, parts and even entire set of genomes. While genetic sequencing is associated with reading DNA, and genetic engineering is related to copy, cut and paste these DNAs, synthetic biology involves writing as well as programming DNAs to build genomes from the scratch and understand how life works. Synthetic biology can be applied to a large number of industrial segments, and holds potential to develop spectacular systems and processes such as nitrogen fixation and create edible wonder protein with various essential amino acids. In near future, majority of research activities in this field are expected to focus on energy products, chemicals, pharmaceuticals and diagnostic tools. In addition, the concept is anticipated to play a major role in addressing concerns associated with energy, water and cultivable land to reduce carbon footprint and drastically change the way people farm and eat.

With the U.S. leading the way, sustainable products are poised to emerge into a big global opportunity. From sustainable chemistry to renewable energy & biofuels, synthetic biology holds the potential to eliminate market barriers to developing sustainable, environment friendly products, materials & services. Interestingly, the global COVID-19 pandemic has opened opportunities for new approaches and accelerated several innovative trends that were already underway. During the early stages of the global COVID-19 outbreak, 3D printing or additive manufacturing was found to play an important role in urgently producing much needed personal protective equipment and ventilator equipment locally for bridging the shortage caused by disruptions in global supply chains. The world is also now looking for ways of developing vaccines and treatments for coronavirus, which is where synthetic biology can contribute at a much faster pace as compared to conventional approaches. Synthetic biology’s toolset seems poised to create vaccines as well as treatments that are not only more potent and stable, but also are quicker and easier to manufacture. These benefits are extremely critical in addressing the existing health crisis as well as enabling health systems and governments to quickly respond to any unanticipated and new future threats. While synthetic biology has been for long bringing profound changes to the process of producing chemicals, materials, and food, as well as helping addressing other major global challenges, such as food security, chronic disease, and climate change, it is the COVID-19 pandemic that could eventually provide a breakout moment for synthetic biology.

Competitors identified in this market include, among others,

  • Codexis, Inc.

  • Editas Medicine, Inc.

  • Eurofins Scientific SE

  • GENEWIZ

  • GeneWorks Pty., Ltd.

  • GenScript USA, Inc.

  • Integrated DNA Technologies, Inc.

  • OriGene Technologies, Inc.

  • OriGene Technologies, Inc.

  • Proterro, Inc.

  • Synthetic Genomics, Inc.

  • Synthorx, Inc.

  • TeselaGen Biotechnology

  • Thermo Fisher Scientific, Inc.

  • Twist Bioscience




Read the full report: https://www.reportlinker.com/p01375238/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE I-1

II. EXECUTIVE SUMMARY II-1

1. MARKET OVERVIEW II-1
Impact of Covid-19 and a Looming Global Recession II-1
COVID-19 Pandemic Poised to Drive Demand for Synthetic Biology II-1
Exhibit 1: COVID-19 Vaccines in Pipeline by Technology II-4
Synthetic Biologists Create Slow-Growing Version of COVID-19 as
Vaccine Candidate II-5
Role of Synthetic Biology in Combating COVID-19 II-5
Synthetic Biology: A Prelude II-6
Growing Importance of Synthetic Biology II-7
Applications of Synthetic Biology II-9
Synthetic Biology Tools II-10
Technologies Involved II-10
Current and Future Analysis II-11
Regional Landscape II-12
Major Challenges and Concerns II-13
Teeming R&D Funding & Potential to Alter Molecular Landscape
Enable Global Synthetic Biology Market to Remain in High
Spirits II-14
Competitive Landscape II-15
Major Players by Industry Verticals II-15
Synthetic Biology Startups Get Aggressive on Bioengineered
Product Commercialization II-16
Compelling Breakthroughs Drive Funding II-16
Top Funded Synthetic Biology Startups in Q2 2020 II-18
Recent Market Activity II-19

2. FOCUS ON SELECT PLAYERS II-21

3. MARKET TRENDS & DRIVERS II-23
Synthetic Biology Market Witnesses Significant Rise in Investments II-23
Importance of Synthetic Biology for Investments II-23
Efforts from Leading Players Bodes Well for Market Growth II-24
Patent Landscape Gets Richer II-25
Exhibit 2: Synthetic Biology Patent Landscape by Assignee
Countries (in %) : 2003-2018 II-26
Exhibit 3: Top 15 Patent Assignees in Synthetic Biology Domain:
2003-2018 II-27
Select Patent Assignees for Synthetic Biology in the US: 2019 II-28
Robotics and Workflow Automation Support Market Expansion II-29
Advancements in Instrumentation Augurs Well II-29
Improvements in Computer-Aided Biology II-30
Fusion of AI and Synthetic Biology Expands Opportunities II-31
Synthetic Biology Brings a Paradigm Shift in the Field of
Biological Research II-32
DNA Sequencing Plays an Important Role II-33
Plummeting Cost of DNA Sequencing Bolsters Market Growth II-33
Exhibit 4: Cost per Genome Sequencing: 2001-2020 II-34
Food Scarcity to Fuel Synthetic Biology Application in Agriculture II-35
Select Companies Engaged in Making Food Using Synthetic Biology II-36
Synthetic Biology Aids in Development of Exotic and
Artificially Grown Meats and Proteins to Meet Future Food
Demand II-37
Growing Demand for GM Crops Opens Up Growth Avenues II-37
Synthetic Biology-based Ingredients Gain Traction II-38
Role of Synthetic Biology in Producing Plants with Desirable
Characteristics II-38
Synthetic Biology Gains Prominence in Biomedical Applications II-39
Synthetic Genes Open up a New World of Drug Development II-40
Synthetic Biology to Transform Healthcare with Captivating
Advances in Biomedicine II-40
Synthetic Biology Enables Creation of Advanced Biosensing Systems II-41
Synthetic Biology Gains Significance in Production of Bio-Based
Chemicals and Biofuels II-42
Exhibit 5: Global Biofuels Market in US$ Billion: 2019 and 2024 II-44
Synthetic Biology Gains Importance as Focus on Carbon Recycling
Increases II-44
Synthetic Biology Disrupts the Cosmetics Sector II-45
Capability of Synthetic Biology in Environmental Applications II-45
Synthetic Biology Creates Buzz as Key Enabler of Exciting &
Dynamic Applications for Diverse Domains II-47
Synthetic Biology for Advanced, Multifunctional Materials II-47
Genetically Engineered Fabrics and Sustainable Dyes Using
Synthetic Biology to Transform Textile Industry II-48
Select Synthetic Biology Offerings in Textile Industry II-49

4. GLOBAL MARKET PERSPECTIVE II-50
Table 1: World Current & Future Analysis for Synthetic Biology
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 II-50

Table 2: World Historic Review for Synthetic Biology by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-51

Table 3: World 12-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets for Years 2015, 2020 & 2027 II-52

Table 4: World Current & Future Analysis for Oligonucleotides &
Synthetic DNA by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 II-53

Table 5: World Historic Review for Oligonucleotides & Synthetic
DNA by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-54

Table 6: World 12-Year Perspective for Oligonucleotides &
Synthetic DNA by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2020 & 2027 II-55

Table 7: World Current & Future Analysis for Enzymes by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 II-56

Table 8: World Historic Review for Enzymes by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 II-57

Table 9: World 12-Year Perspective for Enzymes by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2015, 2020 & 2027 II-58

Table 10: World Current & Future Analysis for Cloning
Technology Kits by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-59

Table 11: World Historic Review for Cloning Technology Kits by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-60

Table 12: World 12-Year Perspective for Cloning Technology Kits
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-61

Table 13: World Current & Future Analysis for Synthetic Cells
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 II-62

Table 14: World Historic Review for Synthetic Cells by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-63

Table 15: World 12-Year Perspective for Synthetic Cells by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-64

Table 16: World Current & Future Analysis for Xeno-Nucleic
Acids (XNA) by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 II-65

Table 17: World Historic Review for Xeno-Nucleic Acids (XNA) by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-66

Table 18: World 12-Year Perspective for Xeno-Nucleic Acids
(XNA) by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2015, 2020 & 2027 II-67

Table 19: World Current & Future Analysis for Chassis Organism
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 II-68

Table 20: World Historic Review for Chassis Organism by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-69

Table 21: World 12-Year Perspective for Chassis Organism by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-70

Table 22: World Current & Future Analysis for Nucleotide
Synthesis & Sequencing by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 II-71

Table 23: World Historic Review for Nucleotide Synthesis &
Sequencing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 II-72

Table 24: World 12-Year Perspective for Nucleotide Synthesis &
Sequencing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2015, 2020 & 2027 II-73

Table 25: World Current & Future Analysis for Genome
Engineering by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 II-74

Table 26: World Historic Review for Genome Engineering by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-75

Table 27: World 12-Year Perspective for Genome Engineering by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-76

Table 28: World Current & Future Analysis for Microfluidics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 II-77

Table 29: World Historic Review for Microfluidics by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2015 through 2019 II-78

Table 30: World 12-Year Perspective for Microfluidics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-79

Table 31: World Current & Future Analysis for Other
Technologies by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 II-80

Table 32: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-81

Table 33: World 12-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-82

Table 34: World Current & Future Analysis for Pharmaceuticals &
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 II-83

Table 35: World Historic Review for Pharmaceuticals &
Diagnostics by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2015 through
2019 II-84

Table 36: World 12-Year Perspective for Pharmaceuticals &
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific
and Rest of World for Years 2015, 2020 & 2027 II-85

Table 37: World Current & Future Analysis for Industrial by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 II-86

Table 38: World Historic Review for Industrial by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2015 through 2019 II-87

Table 39: World 12-Year Perspective for Industrial by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-88

Table 40: World Current & Future Analysis for Food &
Agriculture by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 II-89

Table 41: World Historic Review for Food & Agriculture by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-90

Table 42: World 12-Year Perspective for Food & Agriculture by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-91

Table 43: World Current & Future Analysis for Environmental by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2020 through 2027 II-92

Table 44: World Historic Review for Environmental by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2015 through 2019 II-93

Table 45: World 12-Year Perspective for Environmental by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-94

Table 46: World Current & Future Analysis for Other
Applications by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 II-95

Table 47: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2015 through 2019 II-96

Table 48: World 12-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2015, 2020 & 2027 II-97

III. MARKET ANALYSIS III-1

GEOGRAPHIC MARKET ANALYSIS III-1

UNITED STATES III-1
Table 49: USA Current & Future Analysis for Synthetic Biology
by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning
Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and
Chassis Organism - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-1

Table 50: USA Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 III-2

Table 51: USA 12-Year Perspective for Synthetic Biology by Tool -
Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027 III-3

Table 52: USA Current & Future Analysis for Synthetic Biology
by Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-4

Table 53: USA Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 III-5

Table 54: USA 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Sales for Nucleotide
Synthesis & Sequencing, Genome Engineering, Microfluidics and
Other Technologies for the Years 2015, 2020 & 2027 III-6

Table 55: USA Current & Future Analysis for Synthetic Biology
by Application - Pharmaceuticals & Diagnostics, Industrial,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-7

Table 56: USA Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 III-8

Table 57: USA 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Sales for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2020 &
2027 III-9

CANADA III-10
Table 58: Canada Current & Future Analysis for Synthetic
Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes,
Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids
(XNA) and Chassis Organism - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 III-10

Table 59: Canada Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 III-11

Table 60: Canada 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027 III-12

Table 61: Canada Current & Future Analysis for Synthetic
Biology by Technology - Nucleotide Synthesis & Sequencing,
Genome Engineering, Microfluidics and Other Technologies -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-13

Table 62: Canada Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 III-14

Table 63: Canada 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Sales for Nucleotide
Synthesis & Sequencing, Genome Engineering, Microfluidics and
Other Technologies for the Years 2015, 2020 & 2027 III-15

Table 64: Canada Current & Future Analysis for Synthetic
Biology by Application - Pharmaceuticals & Diagnostics,
Industrial, Food & Agriculture, Environmental and Other
Applications - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-16

Table 65: Canada Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 III-17

Table 66: Canada 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Sales for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2020 &
2027 III-18

JAPAN III-19
Table 67: Japan Current & Future Analysis for Synthetic Biology
by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning
Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and
Chassis Organism - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-19

Table 68: Japan Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 III-20

Table 69: Japan 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027 III-21

Table 70: Japan Current & Future Analysis for Synthetic Biology
by Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-22

Table 71: Japan Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 III-23

Table 72: Japan 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Sales for Nucleotide
Synthesis & Sequencing, Genome Engineering, Microfluidics and
Other Technologies for the Years 2015, 2020 & 2027 III-24

Table 73: Japan Current & Future Analysis for Synthetic Biology
by Application - Pharmaceuticals & Diagnostics, Industrial,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-25

Table 74: Japan Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 III-26

Table 75: Japan 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Sales for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2020 &
2027 III-27

CHINA III-28
Table 76: China Current & Future Analysis for Synthetic Biology
by Tool - Oligonucleotides & Synthetic DNA, Enzymes, Cloning
Technology Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and
Chassis Organism - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 III-28

Table 77: China Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 III-29

Table 78: China 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the
Years 2015, 2020 & 2027 III-30

Table 79: China Current & Future Analysis for Synthetic Biology
by Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 III-31

Table 80: China Historic Review for Synthetic Biology by
Technology - Nucleotide Synthesis & Sequencing, Genome
Engineering, Microfluidics and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 III-32

Table 81: China 12-Year Perspective for Synthetic Biology by
Technology - Percentage Breakdown of Value Sales for Nucleotide
Synthesis & Sequencing, Genome Engineering, Microfluidics and
Other Technologies for the Years 2015, 2020 & 2027 III-33

Table 82: China Current & Future Analysis for Synthetic Biology
by Application - Pharmaceuticals & Diagnostics, Industrial,
Food & Agriculture, Environmental and Other Applications -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 III-34

Table 83: China Historic Review for Synthetic Biology by
Application - Pharmaceuticals & Diagnostics, Industrial, Food &
Agriculture, Environmental and Other Applications Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2015 through 2019 III-35

Table 84: China 12-Year Perspective for Synthetic Biology by
Application - Percentage Breakdown of Value Sales for
Pharmaceuticals & Diagnostics, Industrial, Food & Agriculture,
Environmental and Other Applications for the Years 2015, 2020 &
2027 III-36

EUROPE III-37
Table 85: Europe Current & Future Analysis for Synthetic
Biology by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2020 through 2027 III-37

Table 86: Europe Historic Review for Synthetic Biology by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 III-38

Table 87: Europe 12-Year Perspective for Synthetic Biology by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2015, 2020 & 2027 III-39

Table 88: Europe Current & Future Analysis for Synthetic
Biology by Tool - Oligonucleotides & Synthetic DNA, Enzymes,
Cloning Technology Kits, Synthetic Cells, Xeno-Nucleic Acids
(XNA) and Chassis Organism - Independent Analysis of Annual
Sales in US$ Thousand for the Years 2020 through 2027 III-40

Table 89: Europe Historic Review for Synthetic Biology by Tool -
Oligonucleotides & Synthetic DNA, Enzymes, Cloning Technology
Kits, Synthetic Cells, Xeno-Nucleic Acids (XNA) and Chassis
Organism Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2015 through 2019 III-41

Table 90: Europe 12-Year Perspective for Synthetic Biology by
Tool - Percentage Breakdown of Value Sales for Oligonucleotides &
Synthetic DNA, Enzymes, Cloning Technology Kits, Synthetic
Cells, Xeno-Nucleic Acids (XNA) and Chassis Organism for the

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p01375238/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001